Adjustment of phenprocoumon dosage utilizing a pharmacokinetic model.
According to a pharmacokinetic model, the adjustment of a phenprocoumon (PPC) standard dosage based on experimentally determined means values of the parameters volume of distribution and biological half-life will yield in more than 50% of the individuals the desired plasma PPC concentration. In 25 patients it was tested, whether the thus derived loading and maintenance doses, 376.8 and 35.2 micrograms PPC per kg b. wt., resp., actually lead to the predicted optimum plasma PPC concentration of 2.0 micrograms/ml. After initiating dosage, the plasma PPC concentrations were determined over a time period of 30 days. As predicted by the model, in 72% of the patients the average steady-state plasma PPC concentrations were within the range of 1.7 and 2.3 micrograms/ml. The data obtained were used to newly calculate mean values of the volume of distribution, the biological half-life, and the total body clearance of PPC. The mean biological half-life of PPC derived was somewhat shorter than that used for the calculation of the standard dose. Quick-values were estimated concomitantly with the plasma PPC concentrations. They revealed an optimum anticoagulation (15-25%) in 96% of the patients.
Böhm
K
K
Department of Internal Medicine, Medical Academy Erfurt, GDR.
Vogel
G
G
Barthel
W
W
D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001835:Body Weight; D004334:Drug Administration Schedule; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D010644:Phenprocoumon / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D015110:4-Hydroxycoumarins; D010644:Phenprocoumon